Shandong Bainuo Pharmaceutical DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Jazz Pharma receive FDA approval for biliary tract cancer treatment

21 Nov 2024

// REUTERS

Trump likely to pick Johns Hopkins surgeon, for FDA, sources say

21 Nov 2024

// REUTERS

UCB receives FDA approval for BIMZELX For hidradenitis suppurativa

21 Nov 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

BMWS24

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Shandong Bainuo Pharmaceutical Co., Ltd. was established in August 2000 and is headquartered in Jinan City, Shandong Province. It is committed to building a leading pharmaceutical R&D technology platform company in China. It has passed the ISO9001 international quality management system and intellectual property management system certification, and established the "R&D Industry " Academician Workstation" , the vice-chairman unit of the Pharmaceutical Research and Development Branch of the All-China Federation of Industry and Commerce, and obtained the "Drug Production License" of the first research institution in Shandong Province.